Vivos Therapeutics (VVOS) Intangibles (2019 - 2026)
Vivos Therapeutics' (VVOS) quarterly Intangibles came in at $3.8 million in Q1 2026, up 972.35% year-on-year from $358000.0 in Q1 2025, and down 5.09% on a QoQ basis from $4.0 million in Q4 2025.
Vivos Therapeutics (VVOS) Intangibles (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 8 years of Intangibles data on file, last reported at $3.8 million in Q1 2026.
- On a quarterly basis, Intangibles rose 972.35% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 972.35% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, up 889.0% from the prior year.
- Intangibles for Q1 2026 stood at $3.8 million, down from $4.0 million in the prior quarter.
- Over the last five years, Intangibles for VVOS reached as high as $4.0 million in Q4 2025 and fell as low as $302000.0 in Q4 2022.
- Historically, Intangibles has averaged $1.0 million across 5 years, with a median of $409000.0 in 2024.
- Across the five-year window, Intangibles plunged 87.22% in 2022 and soared 972.35% in 2026, its largest moves.
- Year by year, Intangibles stood at $302000.0 in 2022, then soared by 39.07% to $420000.0 in 2023, then retreated by 2.62% to $409000.0 in 2024, then soared by 889.0% to $4.0 million in 2025, then fell by 5.09% to $3.8 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $3.8 million in Q1 2026, $4.0 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.14 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 882.00 Mn |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | 3.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.84 Mn |
| Dec 31, 2025 | 4.05 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | 409,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Mar 31, 2024 | 408,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 445,000.00 |
| Mar 31, 2023 | 458,000.00 |
| Dec 31, 2022 | 302,000.00 |
| Sep 30, 2022 | 312,000.00 |
| Jun 30, 2022 | 322,000.00 |
| Mar 31, 2022 | 331,000.00 |
| Dec 31, 2021 | 341,000.00 |
| Sep 30, 2021 | 350,585.00 |
| Jun 30, 2021 | 2.52 Mn |